Cargando…
Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with In Vitro Anti-Tumor Effects
The c-Met protein is a receptor tyrosine kinase involved in cell growth, proliferation, survival, and angiogenesis of several human tumors. Overexpression of c-Met has been found in gastric cancers and correlated with a poor prognosis. Indirubin is the active component of Danggui Longhui Wan, which...
Autores principales: | Ndolo, Karyn Muzinga, An, Su Jin, Park, Kyeong Ryang, Lee, Hyo Jeong, Yoon, Kyoung Bin, Kim, Yong-Chul, Han, Sun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430219/ https://www.ncbi.nlm.nih.gov/pubmed/30060294 http://dx.doi.org/10.4062/biomolther.2018.091 |
Ejemplares similares
-
Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells
por: Ndolo, Karyn Muzinga, et al.
Publicado: (2017) -
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
por: Blažević, Tina, et al.
Publicado: (2015) -
Synthesis and antibacterial activity studies in vitro of indirubin-3′-monoximes
por: Yang, Fen-Fen, et al.
Publicado: (2022) -
Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells
por: KIM, DONG CHUL, et al.
Publicado: (2016) -
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents
por: Efstathiou, Antonia, et al.
Publicado: (2018)